Tayanes, Gemma .

HRN: 28-80-43  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2026
CEFUROXIME 1.5GM (VIAL)
04/07/2026
04/14/2026
IV
1.5
Ptor
Pelvic Lap
Remove - Pending Acceptance
04/07/2026
CLINDAMYCIN 300MG (CAP)
04/07/2026
04/14/2026
PO
1 Tab
BID
S/P Pelvic Lap
Remove - Pending Acceptance
04/07/2026
DOXYCYCLINE 100MG (CAP)
04/07/2026
04/14/2026
PO
1 Tab
BID
S/P Pelvic Lap
Remove - Pending Acceptance
04/07/2026
MUPIROCIN 2%, 15G (TUBE)
04/07/2026
04/14/2026
TOPICAL
Pea Sized
OD
S/P Pelvic Lap
Remove - Pending Acceptance
04/07/2026
MUPIROCIN 2%, 15G (TUBE)
04/07/2026
04/14/2026
TOPICAL
Pea Sized
OD
S/P Pelvic Lap
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: